Coe Mary Ellen 4

What Happened
Mary Ellen Coe, a director of Merck & Co. (MRK), was granted 1,853.1 phantom stock units on 2026-05-29. The units are reported at a grant price of $118.72 each for a total reported value of $220,000. This was an award/acquisition (derivative award), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-05-29; Form 4 filed: 2026-06-02 (filed within the typical 2-business-day window).
• Transaction type: A (award/grant/acquisition of derivative).
• Units granted: 1,853.1 phantom stock units at $118.72 per unit; total reported value $220,000.
• Shares/units owned after transaction: not specified in the excerpt of the filing provided.
• Relevant footnotes from the filing:
  • F1: 1-for-1 (unit-to-share ratio).
  • F2: Phantom stock units are to be settled 100% in cash upon the reporting person’s termination of service, per the Plan for Deferred Payment of Directors' Compensation.
  • F3: Holdings (where reported) may include shares from dividend reinvestment transactions.

Context
These are phantom (cash‑settled) stock units awarded as director compensation — they do not represent an immediate purchase of common stock and will be settled in cash per the plan terms upon termination. Such grants are routine director compensation and are informational rather than a direct buy/sell signal about the insider’s market view.